Press Releases Items Per Page 102550 News Category FinancialGeneral Year None202020192018201720162015201420132012201120102009200820072006 First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology Jun 13, 2019 Nektar Therapeutics to Host Webcast Conference Call with Immunology Expert for Analysts & Investors During 2019 European Congress of Rheumatology (EULAR 2019) Jun 11, 2019 Nektar Therapeutics Presents Biomarker and Clinical Data from PIVOT-02 Phase 2 Study of Bempegaldesleukin with Nivolumab at 2019 ASCO Annual Meeting Jun 01, 2019 Nektar Announces the Launch of Inheris Biopharma, Inc. May 23, 2019 Nektar Therapeutics Announces Five Accepted Abstracts at 2019 American Society of Clinical Oncology's (ASCO) Annual Meeting May 15, 2019 Nektar Therapeutics Reports Financial Results for the First Quarter of 2019 May 08, 2019 Nektar to Announce Financial Results for the First Quarter 2019 on Wednesday, May 8, 2019, After Close of U.S.-Based Financial Markets May 01, 2019 Nektar Therapeutics Presents Preclinical Data on its Immuno-Oncology Pipeline Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2019 Apr 02, 2019 Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American Association for Cancer Research (AACR) Annual Meeting 2019 Apr 01, 2019 Nektar Therapeutics to Webcast Presentation at the Cowen and Company 39th Annual Health Care Conference Mar 06, 2019 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »